CSIMarket Company Name, Ticker, Customers, else..
 
Calcimedica Inc   (NASDAQ: CALC)
 
Price: $2.0200 $-0.15 -6.912%
Day's High: $2.109999895095825 Week Perf: 1 %
Day's Low: $ 1.99 30 Day Perf: 193.6 %
Volume (M): 122,568 52 Wk High: $ 7.20
Volume (M$): $ 0 52 Wk Avg: $2.03
Open: $2.11 52 Wk Low: $0.44



 Market Capitalization (Millions $) 35
 Shares Outstanding (Millions) 17
 Employees 16
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


Calcimedica Inc is a biopharmaceutical company that focuses on the discovery and development of novel calcium channel inhibitors for the treatment of various diseases. The company's mission is to provide safer and more effective therapeutic options for patients with unmet medical needs. Calcimedica's research and development efforts revolve around leveraging the role of calcium signaling in disease pathways, with a specific focus on immune, neurological, and fibrotic disorders. By targeting calcium channels, the company aims to modulate cellular responses and restore normal physiological functions. Calcimedica's innovative approach has the potential to address a wide range of diseases and improve patient outcomes.


   Company Address: 505 Coast Boulevard South La Jolla 92037 CA
   Company Phone Number: 952-5500   Stock Exchange / Ticker: NASDAQ CALC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JNJ        1.23% 
MRK        0.47% 
PFE   -2.35%    
TEVA        1.97% 
VRTX   -2.87%    
VTRS        0.61% 
• View Complete Report
   



Stocks on the Move

Evaluating CalciMedica Inc.s Market Challenges and Potential Upside Amidst Industry Setbacks

Published Mon, Aug 5 2024 4:02 PM UTC

As CalciMedica Inc. (NASDAQ: CALC) continues to navigate the complexities of being a clinical-stage biopharmaceutical company, recent developments highlight significant challenges as well as intra-industry competition impacting its market performance. In the last trading session, CALC shares demonstrated a notable slowdown, trailing behind broader market trends, and raising ...
Stocks on the Move

CalciMedicas Breakthrough Treatment Offers Hope for Acute Pancreatitis Patients

Published Sun, Jun 30 2024 12:46 PM UTC

CalciMedica Inc, a clinical-stage biopharmaceutical company specializing in the development of novel calcium release-activated calcium (CRAC) channel inhibitors, is making significant strides in the field of acute pancreatitis (AP) treatment. The company recently announced positive topline data from its Phase 2b CARPO trial, evaluating the efficacy of Auxora in AP patients w...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 6.27
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.71
Working Capital Ratio 4.93
Leverage Ratio (MRQ) 2.54
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -5.15 $
Revenues (TTM) -
Cash Flow (TTM) 0.13 $
Cash 1.09 $
Book Value 0.32 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,327,500
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.